The DOI matches its Crossref record; 214 of the 215 references it cites were found in a registry or an index; none of the 23 sources its claims cite is checked for support yet.
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Open accessAbstract
IMPORTANCE: Primary care clinicians find managing chronic pain challenging. Evidence of long-term efficacy of opioids for chronic pain is limited. Opioid use is associated with serious risks, including opioid use disorder and overdose. OBJECTIVE: To provide recommendations about opioid prescribing for primary care clinicians treating adult patients with chronic pain outside of active cancer treatment, palliative care, and end-of-life care. PROCESS: The Centers for Disease Control and Prevention (CDC) updated a 2014 systematic review on effectiveness and risks of opioids and conducted a supplemental review on benefits and harms, values and preferences, and costs. CDC used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework to assess evidence type and determine the recommendation category. EVIDENCE SYNTHESIS: Evidence consisted of observational studies or randomized clinical trials with notable limitations, characterized as low quality using GRADE methodology. Meta-analysis was not attempted due to the limited number of studies, variability in study designs and clinical heterogeneity, and methodological shortcomings of studies. No study evaluated long-term (≥1 year) benefit of opioids for chronic pain. Opioids were associated with increased risks, including opioid use disorder, overdose, and death, with dose-dependent effects. RECOMMENDATIONS: There are 12 recommendations. Of primary importance, nonopioid therapy is preferred for treatment of chronic pain. Opioids should be used only when benefits for pain and function are expected to outweigh risks. Before starting opioids, clinicians should establish treatment goals with patients and consider how opioids will be discontinued if benefits do not outweigh risks. When opioids are used, clinicians should prescribe the lowest effective dosage, carefully reassess benefits and risks when considering increasing dosage to 50 morphine milligram equivalents or more per day, and avoid concurrent opioids and benzodiazepines whenever possible. Clinicians should evaluate benefits and harms of continued opioid therapy with patients every 3 months or more frequently and review prescription drug monitoring program data, when available, for high-risk combinations or dosages. For patients with opioid use disorder, clinicians should offer or arrange evidence-based treatment, such as medication-assisted treatment with buprenorphine or methadone. CONCLUSIONS AND RELEVANCE: The guideline is intended to improve communication about benefits and risks of opioids for chronic pain, improve safety and effectiveness of pain treatment, and reduce risks associated with long-term opioid therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 23 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of primary importance, nonopioid therapy is preferred for treatment of chronic pain. Opioids should be used only when benefits for pain and function are expected to outweigh risks.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When opioids are used, clinicians should prescribe the lowest effective dosage, carefully reassess benefits and risks when considering increasing dosage to 50 morphine milligram equivalents or more per day,”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“Several nonpharmacologic and nonopioid pharmacologic treatments were found to be effective for chronic pain in studies ranging in duration from 2 weeks to 6 months48–66 (Table 3).”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Contextual Evidence Review
What the sources say
- Not matchedcites [48]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [49]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [50]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [51]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [52]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [53]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [54]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No study evaluated long-term (≥1 year) benefit of opioids for chronic pain.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The recommendations in the guideline are voluntary, rather than prescriptive standards. They are based on emerging evidence, including observational studies or randomized clinical trials with notable limitations.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > CONCLUSIONS AND RELEVANCE
None of the sources cited for this claim have been checked yet.
In the paper
“Studies examining patients who underwent low-risk surgery or experienced low back pain from injury revealed that opioid therapy prescribed for acute pain was associated with greater likelihood of long-term use.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Clinical Evidence Review
What the sources say
- Not checked yetcites [46]
- Not checked yetcites [47]
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No study evaluated the effectiveness of risk mitigation strategies.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Guideline Development Process > Clinical Evidence Review
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Evidence consisted of observational studies or randomized clinical trials with notable limitations, characterized as low quality using GRADE methodology.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Opioids were associated with increased risks, including opioid use disorder, overdose, and death, with dose-dependent affects.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > EVIDENCE SYNTHESIS
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Before starting opioids, clinicians should establish treatment goals with patients and consider how opioids will be discontinued if benefits do not outweigh risks.”
§ CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016 > Abstract > RECOMMENDATIONS
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“A study of almost 100,000 patients found that the average rate of tapering was 34.0% of the original dose per month and more than a quarter of patients were tapering at a rate faster than 40% of their original dose per month,43,49 even higher than the maximum rate recommended by the CDC. 1”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [1]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, opioids are significantly less effective against chronic pain, such as neuropathic pain, fibromyalgia, and low-back pain, and tolerance develops to the analgesic effects of opioids, thus necessitating the need for increasingly higher doses to sustain analgesia (McQuay, 1988;Dowell et al., 2016).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Dowell et al., 2016
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The influential Centres for Disease Control (CDC) Guideline for Prescribing Opioids recommends a linear reduction of opioid doses: ‘A decrease of 10% of the original dose per week’ or ‘slower tapers (e.g. 10% per month)’ for longer term users (Figure 1(a)). 1”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [1]
In the citing paper
“Opioids are also associated with substantial systemic harm such as worsening psychopathology, addiction, tolerance, and premature death. 24”
From Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome (2021) · cites this paper as [24]
In the citing paper
“The Centers for Disease Control and Prevention and US Food and Drug Administration issued warnings in 2016 to make prescribers and patients aware of these risks.19,34”
From Patterns in Outpatient Benzodiazepine Prescribing in the United States (2019) · cites this paper as [34]
In the citing paper
“evidence of their longterm efficacy and safety is limited.6”
From Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis (2020) · cites this paper as [6]
In the citing paper
“Although opioids are considered to be useful in managing a wide continuum of pain, including acute, procedural, and chronic pain”
From Mind-Body Therapies for Opioid-Treated Pain: A Systematic Review and Meta-analysis (2020) · cites this paper as [6]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,842
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.03.006 · Cited by 4,057
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094
Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796
Chou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718
Self-citationCDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697
Self-citationPsychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
Flagged first, then by citations
1 of the 215 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 1,036
Cho, J., Spence, M. M., Niu, F., Hui, R. L., Gray, P., & Steinberg, S. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05545-y · Cited by 84
SEOM clinical guideline for treatment of cancer pain (2017)
Jara, C., del Barco, S., Grávalos, C., Hoyos, S., Hernández, B., Muñoz-Mateu, M., Quintanar, T., Meana, J. A., Rodriguez, C. A., & Peñas, R. D. L. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1791-2 · Cited by 82
Goals of Chronic Pain Management: Do Patients and Primary Care Physicians Agree and Does it Matter?
Henry, S. G., Bell, R. A., Fenton, J. J., & Kravitz, R. L. (2017) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000000488 · Cited by 87
The perioperative effects of chronic preoperative opioid use on shoulder arthroplasty outcomes
Cheah, J. W., Sing, D. C., McLaughlin, D. C., Feeley, B. T., Benjamin, C., & Zhang, A. L. (2017) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2017.05.016 · Cited by 81
Treatment of Interstitial Lung Disease Associated Cough
Birring, S. S., Kavanagh, J. E., Irwin, R. S., Keogh, K. A., Lim, K. G., Ryu, J. H., Adams, T. M., Altman, K. W., Azoulay, É., Barker, A. F., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.06.038 · Cited by 81
Testosterone deficiency in non-cancer opioid-treated patients
Coluzzi, F., Billeci, D., Maggi, M., & Corona, G. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0964-3 · Cited by 82
Opioid Prescribing to US Children and Young Adults in 2019
Chua, K., Brummett, C. M., Conti, R. M., & Bohnert, A. S. B. (2021) · PEDIATRICS · doi:10.1542/peds.2021-051539 · Cited by 83
Gushgari, A. J., Venkatesan, A. K., Chen, J., Steele, J. C., & Halden, R. U. (2019) · Water Research · doi:10.1016/j.watres.2019.06.003 · Cited by 83
Classics in Chemical Neuroscience: Baclofen
Kent, C. N., Park, C., & Lindsley, C. W. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00254 · Cited by 80
Cryoablation for Palliation of Painful Bone Metastases: The MOTION Multicenter Study
Jennings, J. W., Prologo, J. D., Garnon, J., Gangi, A., Buy, X., Palussière, J., Kurup, A. N., Callstrom, M. R., Genshaft, S. J., Abtin, F. G., et al. (2021) · Radiology Imaging Cancer · doi:10.1148/rycan.2021200101 · Cited by 80
Benintendi, A., Kosakowski, S., Lagisetty, P., Larochelle, M. R., Bohnert, A. S. B., & Bazzi, A. R. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108664 · Cited by 80
Park, T. W., Lin, L., Hosanagar, A., Kogowski, A., Paige, K., & Bohnert, A. (2016) · Journal of addiction medicine · doi:10.1097/adm.0000000000000245 · Cited by 68
Guanidinium Toxins and Their Interactions with Voltage-Gated Sodium Ion Channels
Durán-Riveroll, L. M., & Cembella, A. D. (2017) · Marine Drugs · doi:10.3390/md15100303 · Cited by 83
Medications for opioid use disorder: bridging the gap in care.
Volkow, N. D. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32893-3 · Cited by 79
George, S. Z., Beneciuk, J. M., Lentz, T. A., Wu, S. S., Dai, Y., Bialosky, J. E., & Zeppieri, G. (2018) · Journal of Orthopaedic & Sports Physical Therapy · doi:10.2519/jospt.2018.7811 · Cited by 79
Epidemiology of the U.S. opioid crisis: the importance of the vector
Compton, W. M., & Jones, C. M. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14209 · Cited by 86
Ueberall, M. A. (2020) · Journal of Pain Research · doi:10.2147/jpr.s240011 · Cited by 82
Mathieson, S., Wertheimer, G., Maher, C. G., Lin, C. C., McLachlan, A. J., Buchbinder, R., Pearson, S., & Underwood, M. R. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13026 · Cited by 81
Namba, M. D., Leyrer-Jackson, J. M., Nagy, E. K., Olive, M. F., & Neisewander, J. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.650785 · Cited by 76
Barbour, K. E., Boring, M. A., Helmick, C. G., Murphy, L. B., & Qin, J. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6539a2 · Cited by 80
Earp, B. E., Silver, J. A., Mora, A. N., & BLAZAR, P. E. (2018) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.17.01307 · Cited by 78
Adverse Childhood Experiences Increase Risk for Prescription Opioid Misuse
Merrick, M. T., Ford, D. C., Haegerich, T. M., & Simon, T. R. (2020) · The Journal of Primary Prevention · doi:10.1007/s10935-020-00578-0 · Cited by 84
Self-citationNational Patterns in Prescription Opioid Use and Misuse Among Cancer Survivors in the United States
Jairam, V., Yang, D. X., Verma, V., Yu, J. B., & Park, H. S.-M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.13605 · Cited by 78
Shiels, M. S., Tatalovich, Z., Chen, Y., Haozous, E. A., Hartge, P. A., Nápoles, A. M., Pérez‐Stable, E. J., Rodriquez, E. J., Spillane, S., Thomas, D. A., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.16217 · Cited by 78
Thorn, B. E., Eyer, J. C., Dyke, B. P. V., Torres, C. A., Burns, J. W., Kim, M., Newman, A. K., Campbell, L. C., Anderson, B., Block, P. R., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-0972 · Cited by 78
Recreational marijuana legalization and prescription opioids received by Medicaid enrollees
Shi, Y., Liang, D., Bao, Y., An, R., Wallace, M. S., & Grant, I. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.09.016 · Cited by 80
Nonfatal Drug Overdoses Treated in Emergency Departments — United States, 2016–2017
Vivolo-Kantor, A. M., Hoots, B., Scholl, L., Pickens, C. M. G., Roehler, D. R., Amy Board, Mustaquim, D., Smith, H., Snodgrass, S., & Liu, S. V. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6913a3 · Cited by 77
Opioid Prescribing and Opioid Risk Mitigation Strategies in the Veterans Health Administration
Sandbrink, F., Oliva, E. M., McMullen, T., Aylor, A. R., Harvey, M., Christopher, M. L. D., Cunningham, F. E., Minegishi, T., Emmendorfer, T. R., & Perry, J. M. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06258-3 · Cited by 79
Prescription opioid and benzodiazepine misuse is associated with suicidal ideation in older adults
Schepis, T. S., Simoni‐Wastila, L., & McCabe, S. E. (2018) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4999 · Cited by 78
Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States
Curtis, J. R., Xie, F., Smith, C. R., Saag, K. G., Chen, L., Beukelman, T., Mannion, M. L., Yun, H., & Kertesz, S. G. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40152 · Cited by 77
Risk factors for postoperative opioid use after elective shoulder arthroplasty
Rao, A. G., Chan, P. H., Prentice, H. A., Paxton, E. W., Navarro, R. A., Dillon, M. T., & Singh, A. (2018) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2018.04.018 · Cited by 76
Donohue, J. M., Kennedy, J. N., Seymour, C. W., Girard, T. D., Lo‐Ciganic, W., Kim, C. H., Marroquin, O. C., Moyo, P., Chang, C. H., & Angus, D. C. (2019) · Annals of Internal Medicine · doi:10.7326/m18-2864 · Cited by 77
Multi-Level Regulation of Opioid-Induced Respiratory Depression
Palković, B., Marchenko, V., Zuperku, E. J., Stuth, E. A. E., & Stucke, A. G. (2020) · Physiology · doi:10.1152/physiol.00015.2020 · Cited by 80
Improving Pain Care with Project ECHO in Community Health Centers
Anderson, D., Zlateva, I., Davis, B. E., Bifulco, L., Giannotti, T. E., Coman, E., & Spegman, D. J. (2017) · Pain Medicine · doi:10.1093/pm/pnx187 · Cited by 76
Green, T. C., Davis, C. S., Xuan, Z., Walley, A. Y., & Bratberg, J. P. (2020) · American Journal of Public Health · doi:10.2105/ajph.2020.305620 · Cited by 76
Neuromodulation Management of Chronic Neuropathic Pain in the Central Nervous System
Yu, K., Niu, X., & He, B. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201908999 · Cited by 80
COVID-19 and the Opioid Epidemic: Two Public Health Emergencies That Intersect With Chronic Pain
Manchikanti, L., Vanaparthy, R., Atluri, S., Sachdeva, H., Kaye, A. D., & Hirsch, J. A. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00243-2 · Cited by 78
Patient outcomes after opioid dose reduction among patients with chronic opioid therapy
Hallvik, S. E., Ibrahimi, S. E., Johnston, K. A., Geddes, J., Leichtling, G. J., Korthuis, P. T., & Hartung, D. M. (2021) · Pain · doi:10.1097/j.pain.0000000000002298 · Cited by 75
Gabapentinoid consumption in 65 countries and regions from 2008 to 2018: a longitudinal trend study
Chan, A. Y. L., Yuen, A. S. C., Tsai, D. H., Lau, W. C. Y., Jani, Y. H., Hsia, Y., Osborn, D., Hayes, J., Besag, F., Lai, E. C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40637-8 · Cited by 75
Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults
Guerriero, F. (2017) · World Journal of Clinical Cases · doi:10.12998/wjcc.v5.i3.73 · Cited by 77
Kent, M. L., Tighe, P. J., Belfer, I., Brennan, T. J., Bruehl, S. P., Brummett, C. M., Buckenmaier, C. C., Buvanendran, A., Cohen, R., Desjardins, P. J., et al. (2017) · Pain Medicine · doi:10.1093/pm/pnx019 · Cited by 82
Principles of Burn Pain Management
James, D. L., & Jowza, M. (2017) · Clinics in Plastic Surgery · doi:10.1016/j.cps.2017.05.005 · Cited by 75
Dunn, K. E., Huhn, A. S., Bergeria, C. L., Gipson, C. D., & Weerts, E. M. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258004 · Cited by 74
Nielsen, A., Dusek, J. A., Taylor-Swanson, L. J., & Tick, H. (2022) · Pain Medicine · doi:10.1093/pm/pnac056 · Cited by 79
Opioids and Sleep-Disordered Breathing
Ryswyk, E. V., & Antic, N. A. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.05.022 · Cited by 78
Jones, C. M., Baldwin, G. T., Manocchio, T., White, J. O., & Mack, K. A. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6526a2 · Cited by 74
High-dose opioids for chronic non-cancer pain: an overview of Cochrane Reviews
Els, C., Jackson, T., Hagtvedt, R., Kunyk, D., Sonnenberg, B., Lappi, V. G., & Straube, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012299.pub2 · Cited by 75
Crowley, R. J., Kirschner, N. M., Dunn, A. S., & Bornstein, S. S. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2953 · Cited by 78
Henriksson, J., Wasara, E., & Rönnlund, M. (2016) · Psychological Reports · doi:10.1177/0033294116675086 · Cited by 73
Powell, D., Pacula, R. L., & Taylor, E. A. (2020) · Journal of Health Economics · doi:10.1016/j.jhealeco.2019.102286 · Cited by 73
Alcohol and Opioid Use Disorder in Older Adults: Neglected and Treatable Illnesses
Roux, C. L., Tang, Y., & Drexler, K. P. G. (2016) · Current Psychiatry Reports · doi:10.1007/s11920-016-0718-x · Cited by 75
Knight, K. R., Kushel, M., Chang, J. S., Zamora, K. A., Ceasar, R. C., Hurstak, E., & Miaskowski, C. A. (2017) · Social Science & Medicine · doi:10.1016/j.socscimed.2017.05.043 · Cited by 73
Pasricha, S. V., Tadrous, M., Khuu, W., Juurlink, D. N., Mamdani, M., Paterson, J. M., & Gomes, T. (2018) · Pain · doi:10.1097/j.pain.0000000000001242 · Cited by 76
Mueller, S. R., Koester, S. K., Glanz, J. M., Gardner, E. M., & Binswanger, I. A. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3895-8 · Cited by 70
Role of the Perioperative Surgical Home in Optimizing the Perioperative Use of Opioids
Vetter, T. R., & Kain, Z. N. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002280 · Cited by 71
Federal Response to the Opioid Crisis
Johnson, K., Jones, C., Compton, W. M., Baldwin, G. T., Fan, J., Mermin, J., & Bennett, J. (2018) · Current HIV/AIDS Reports · doi:10.1007/s11904-018-0398-8 · Cited by 72
Pergolizzi, J. V., Rosenblatt, M., & LeQuang, J. A. (2019) · Advances in Therapy · doi:10.1007/s12325-019-00954-1 · Cited by 71
Corcoran, K. L., Bastian, L. A., Gunderson, C. G., Steffens, C., Brackett, A. L., & Lisi, A. J. (2019) · Pain Medicine · doi:10.1093/pm/pnz219 · Cited by 71
Opioids, respiratory depression, and sleep-disordered breathing
Nagappa, M., Weingarten, T. N., Montandon, G., Šprung, J., & Chung, F. F. (2017) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2017.05.004 · Cited by 74
Shmagel, A., Ngo, L., Ensrud, K. E., & Foley, R. N. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.04.004 · Cited by 73
Lam, C. Y., Palsson, O. S., Whitehead, W. E., Sperber, A. D., Tornblom, H., Simren, M., & Aziz, I. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.02.034 · Cited by 71
Jones, C. M. (2016) · Addictive Behaviors · doi:10.1016/j.addbeh.2016.08.027 · Cited by 71
Abuse-deterrent Opioid Formulations
Litman, R. S., Pagán, O. H., & Cicero, T. J. (2017) · Anesthesiology · doi:10.1097/aln.0000000000002031 · Cited by 72
Toyé, F., Seers, K., & Barker, K. L. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018411 · Cited by 70
Giannitrapani, K. F., Glassman, P. A., Vang, D., McKelvey, J., Day, R. T., Dobscha, S. K., & Lorenz, K. (2018) · BMC Family Practice · doi:10.1186/s12875-018-0783-9 · Cited by 70
Management of Pain in the United States—A Brief History and Implications for the Opioid Epidemic
Bernard, S. A., Chelminski, P. R., Ives, T. J., & Ranapurwala, S. I. (2018) · Health Services Insights · doi:10.1177/1178632918819440 · Cited by 75
Opioid Prescribing Behaviors — Prescription Behavior Surveillance System, 11 States, 2010–2016
Strickler, G. K., Kreiner, P. W., Halpin, J., Doyle, E., & Paulozzi, L. J. (2020) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6901a1 · Cited by 72
The pharmacological management of chronic lower back pain
Migliorini, F., Maffulli, N., Eschweiler, J., Betsch, M., Catalano, G., Driessen, A., Tingart, M., & Baroncini, A. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1817384 · Cited by 79
Bennett, A. S., & Elliott, L. C. (2021) · Translational research · doi:10.1016/j.trsl.2021.03.001 · Cited by 70
Cell sources proposed for nucleus pulposus regeneration
Williams, R. J., Tryfonidou, M. A., Snuggs, J., & Maitre, C. L. L. (2021) · JOR Spine · doi:10.1002/jsp2.1175 · Cited by 70
Restless Legs Syndrome and Sleep-Related Movement Disorders
Trotti, L. M. (2017) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000488 · Cited by 70
The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome
Silber, M. H., Becker, P. M., Buchfuhrer, M. J., Earley, C. J., Ondo, W. G., Walters, A. S., & Winkelman, J. W. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.11.007 · Cited by 70
Chronic Opioid Prescribing in Primary Care: Factors and Perspectives
Tong, S. T., Hochheimer, C. J., Brooks, E. M., Sabo, R., Jiang, V., Day, T., Rozman, J. S., Kashiri, P. L., & Krist, A. H. (2019) · The Annals of Family Medicine · doi:10.1370/afm.2357 · Cited by 71
Hadlandsmyth, K., Mosher, H. J., Weg, M. W. V., & Lund, B. C. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-017-4283-8 · Cited by 68
Torrance, N., Mansoor, R., Wang, H., Gilbert, S. E., Macfarlane, G. J., Serpell, M. G., Baldacchino, A., Hales, T. G., Donnan, P. T., Wyper, G. M. A., et al. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.02.022 · Cited by 72
Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative Review
Ardeleanu, V., Alexandra Monica, T. O. M. A., Pafili, K., Παπάνας, Ν., Motofei, I. G., Diaconu, C. C., Rizzo, M., & Stoian, A. P. (2020) · Medicina · doi:10.3390/medicina56010025 · Cited by 75
The Pharmacology and Toxicology of the ‘Holy Trinity’
Horsfall, J. T., & Sprague, J. E. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12655 · Cited by 74
New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation
Salas, J., Scherrer, J. F., Schneider, D., Sullivan, M. D., Bucholz, K. K., Burroughs, T. E., Copeland, L. A., Ahmedani, B. K., & Lustman, P. J. (2016) · Pain · doi:10.1097/j.pain.0000000000000763 · Cited by 72
Merlin, J. S., Patel, K., Thompson, N., Kapo, J. M., Keefe, F., Liebschutz, J. M., Paice, J. A., Somers, T. J., Starrels, J. L., Childers, J. W., et al. (2018) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2018.10.493 · Cited by 70
Opioid Taper Is Associated with Subsequent Termination of Care: a Retrospective Cohort Study
Perez, H. R., Buonora, M. J., Cunningham, C. O., Heo, M., & Starrels, J. L. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05227-9 · Cited by 72
Identifying and classifying opioid‐related overdoses: A validation study
Green, C. A., Perrin, N., Hazlehurst, B. L., Janoff, S. L., DeVeaugh‐Geiss, A., Carrell, D., Grijalva, C. G., Liang, C., Enger, C. L., & COPLAN, P. M. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4772 · Cited by 69
Opioid Management in Older Adults with Chronic Kidney Disease: A Review
Owsiany, M. T., Hawley, C. E., Triantafylidis, L. K., & Paik, J. M. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.06.014 · Cited by 70
Indication-Specific Opioid Prescribing for US Patients With Medicaid or Private Insurance, 2017
Mikosz, C. A., Zhang, K., Haegerich, T. M., Xu, L., Losby, J. L., Greenspan, A. I., Baldwin, G. T., & Dowell, D. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.4514 · Cited by 70
Self-citationMyofascial Pelvic Pain: An Overlooked and Treatable Cause of Chronic Pelvic Pain
Ross, V., Detterman, C., & Hallisey, A. (2021) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.13224 · Cited by 68
Treatment of opioid use disorder in primary care
Buresh, M., Stern, R. S., & Rastegar, D. A. (2021) · BMJ · doi:10.1136/bmj.n784 · Cited by 69
Argoff, C. E., Alford, D. P., Fudin, J., Adler, J. A., Bair, M. J., Dart, R. C., Gandolfi, R., McCarberg, B. H., Stanos, S. P., Gudin, J. A., et al. (2017) · Pain Medicine · doi:10.1093/pm/pnx285 · Cited by 69
Drewes, A. M., Campbell, C. M., Ceyhan, G. O., Delhaye, M., Garg, P. K., van Goor, H., Laquente, B., Morlion, B. J., Olesen, S. S., Singh, V. K., et al. (2018) · Pancreatology · doi:10.1016/j.pan.2018.04.008 · Cited by 68
Increasing Naloxone Awareness and Use
Adams, J. M. (2018) · JAMA · doi:10.1001/jama.2018.4867 · Cited by 67
Long-acting Opioid Use and the Risk of Serious Infections: A Retrospective Cohort Study
Wiese, A. D., Griffin, M. R., Schaffner, W., Stein, C., Greevy, R. A., Mitchel, E. F., & Grijalva, C. G. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy809 · Cited by 69
Substitution of marijuana for opioids in a national survey of US adults
Ishida, J. H., Wong, P. O., Cohen, B. E., Vali, M., Steigerwald, S., & Keyhani, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222577 · Cited by 67
Larochelle, M. R., Lodi, S., Yan, S., Clothier, B. A., Goldsmith, E. S., & Bohnert, A. S. B. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.26523 · Cited by 68
Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations
Langford, A. V., Lin, C. C., Bero, L. A., Blyth, F., Doctor, J. N., Holliday, S., Jeon, Y., Moullin, J. C., Murnion, B. P., Nielsen, S., et al. (2023) · The Medical Journal of Australia · doi:10.5694/mja2.52002 · Cited by 66
A Randomized Trial of Yoga for Children Hospitalized With Sickle Cell Vaso-Occlusive Crisis
Moody, K., Abrahams, B., Baker, R. A., Santizo, R. O., Manwani, D. G., Carullo, V. P., Eugenio, D., & Carroll, A. E. (2017) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2016.12.351 · Cited by 68
Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review
Behar, E., Bagnulo, R., & Coffin, P. O. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.06.005 · Cited by 71
Sander, L. B., Paganini, S., Terhorst, Y., Schlicker, S., Lin, J., Spanhel, K., Buntrock, C., Ebert, D. D., & Baumeister, H. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.1021 · Cited by 63
How States Are Tackling the Opioid Crisis
Wickramatilake, S., Zur, J. B., Mulvaney‐Day, N., Campopiano, M., Selmi, E., & Harwood, H. J. (2017) · Public Health Reports · doi:10.1177/0033354916688206 · Cited by 69
Potentially Inappropriate Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011–2015
Rose, A. J., Bernson, D., Chui, K. K. H., Land, T. G., Walley, A. Y., Larochelle, M. R., Stein, B. D., & Stopka, T. J. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4532-5 · Cited by 66
Rabbi, M., Aung, M. H., Gay, G. K., Reid, M. C., & Choudhury, T. (2018) · Journal of Medical Internet Research · doi:10.2196/10147 · Cited by 71
Factors Associated With Opioid Overdose After an Initial Opioid Prescription
Weiner, S. G., Ibrahimi, S. E., Hendricks, M. A., Hallvik, S. E., Hildebran, C., Fischer, M. A., Weiss, R. D., Boyer, E. W., Kreiner, P. W., Wright, D. A., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.45691 · Cited by 69
The Pain Management of Trauma Patients in the Emergency Department
Fabbri, A., Voza, A., Riccardi, A., Serra, S., & Iaco, F. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093289 · Cited by 70
Metadata
- Authors
- Dowell, D., Haegerich, T. M., & Chou, R.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Dowell, Deborah
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2016-04-19
- Volume
- 315
- Issue
- 15
- Pages
- 1624
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC6390846
- OpenAlex
- W2296986887
- Cited by
- 5,161
- References
- 215
- Citations by year
- 2026: 137 · 2025: 233 · 2024: 272 · 2023: 347 · 2022: 407 · 2021: 733 · 2020: 825 · 2019: 762 · 2018: 701 · 2017: 525 · 2016: 214
- FWCI
- 723.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CC999999)
- Agency for Healthcare Research and Quality
- U.S. Public Health Service (200-2013-M-53890, 15IPA-1505478, 290201200014I)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- opioid prescribing, chronic pain, opioid use disorder, opioid overdose, benzodiazepines, prescription drug monitoring programs, buprenorphine, methadone, medication-assisted treatment, low-dose opioids, primary care
- MeSH terms
- Contraindications, Adult, Analgesics, Opioid, Benzodiazepines, Centers for Disease Control and Prevention, U.S., Communication, Drug Therapy, Combination, Goals, Humans, Drug Prescriptions, Primary Health Care, United States, Randomized Controlled Trials as Topic, Treatment Outcome, Withholding Treatment, Chronic Pain, Acute Pain, Prescription Drug Misuse, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-24 (prompt extract-v1).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
